Recent Clinical Trials

More information about clinical trials below

  • ENGAGE PAS: U.S. Endurant Stent Graft System Post Approval Study 

           Medtronic Vascular, Inc.

  • CREATE PAS: Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study

           ev3, Clinical Protocol P-2611

  • MarrowStim™ PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD)

           Biomet Biologics, IDE Number BB-IDE 13996

  • A Multicenter, Open Label, Prospective, Non-Randomized Study Of The INCRAFT™ Stent Graft System In Subjects With Abdominal Aortic Aneurysms

           Cordis Corporation, P11-4601

  • LEVANT 2: A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Moxy™ Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal Arteries

    Lutonix, CL0002-04

  • SYMPLICITY HTN-3: Renal Denervation in Patients with Uncontrolled Hypertension

    Medtronic, Inc., IP125 1B

  • ROADSTER Study: Investigation of Flow Altered, Short Transcervical Carotid Artery Stenting in Patients with Significant Carotid Artery Disease

    Silk Road Medical, SRM-2012-02

  • EUCLID (Examining the Use of tiCagreLor In paD) Study

    AstraZeneca , DC5135C00001

  • BEST-CLI (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia)

    National Institutes of Health, U01HL107407

  • CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial)

    National Institutes of Health